Exploring the Impact of NSD-ISS, New Biological Definition & Staging System on the Parkinson’s Disease Treatment Landscape
Time: 11:00 am
day: Pre-Conference Day
Details:
- Sharing examples of how the revised AD staging criteria has been applied in clinical trials: how will this inform the adoption of PD staging?
- Highlighting how the NSD-ISS definition will allow for more targeted PD clinical trial designs
- Comparing and contrasting how the molecular staging of AD and PD will impact the treatment landscape
